Vancomycin and rifampin therapy may be inadequate for S. epidermidis prosthetic valve endocarditis due to the risk of developing rifampin resistance.
No takes yet. Share an insight, caveat, or question.
May signal rifampin resistance risk in S. epidermidis prosthetic valve endocarditis; leaves open optimal regimens pending larger studies.
Bruce Chamovitz (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: